Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
about
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma linesB cell activation and the establishment of Epstein-Barr virus latencyBamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsMolecular virology of Epstein-Barr virus.Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infectionPossibilities for active immunotherapy of human cancer.Novel approaches to therapeutic cancer vaccines.Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide.Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMPIn vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein.An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformantsHost cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line raelA fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes.A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytesIsolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs.Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vectorMonoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.Human herpesviruses: a consideration of the latent state.Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.Multiple functions within the Epstein-Barr virus EBNA-3A protein.Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen.The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
P2860
Q24605501-00DF681A-EDB2-45B4-9902-8689A0346119Q28281625-4CF40F0E-6ACD-493D-ACE2-ABB83F6EDAFFQ33552058-F43DE782-1518-4678-B75A-11FD20E4B1A2Q33688737-233C7A2C-43D3-4350-A77C-37A15FFEC47FQ33880494-8CA410E4-3F44-4725-B749-E4843A8C3203Q33929593-8879318F-4C84-4DD5-B87C-46D259E362E5Q34225554-D190B581-38C7-412B-8311-CD09703E9A40Q34590358-8DBB634A-0709-4FB8-9921-C7CCB3944746Q35326752-40529C8A-152D-4903-853C-7ACFE03F1418Q35623327-A306FC7B-1151-4063-B705-6B6D0CD23EFBQ36000904-BF5C9C09-1467-4477-8163-72AD51DF5C98Q36426095-2FB36425-50CC-4E1B-82D5-7089EC8A2F60Q36682729-D8865E92-F199-4CCC-A6E7-107B12783607Q36801187-595E02EC-00BF-442E-8163-33D74B92AEC9Q36806719-8E16ACE1-05CF-4A1E-A4E7-C5A1F61CD1FEQ36812687-DD5A89B0-8F9E-4B00-B81B-97D0A02D181EQ36828590-98A10F92-4A1B-43F0-8552-A1A4104443A4Q36829336-FB9B61FD-EE53-4684-9747-F426BBFE9BFAQ36829470-BA7A180E-16D6-4D18-B7A7-7790DB32AE81Q36866232-18CC06CD-B782-4869-A9EB-AFCDA3D53CA7Q36869917-637F49A2-9808-4000-8545-21ABB5D194C8Q36878602-D89ED1DD-521E-424F-8D63-365CDF6978B2Q36919476-D1E8B89C-BF63-4D13-B052-E23E61A314FAQ36920279-10DC45E6-2222-4DA4-9F1A-C4381370B8ABQ37055693-C92C8149-6384-47AB-991B-94D05D910FCEQ37393138-59BAA0E7-5FFD-4690-BCFA-F3E6FE9FE45BQ37398140-C52FA1AA-A2F9-4DBF-A3AC-3AEA570BE9BEQ37409158-97B162BE-8595-403A-999E-69DFA0DAF485Q39306073-ED71C9DC-A142-4C60-A70F-46A7430ED951Q39577674-21AFC3E9-1890-41C0-88DF-64F408C74DE7Q39748937-4417941D-F11B-46D8-A280-3F661BA8B2BBQ39874105-951C33BD-A667-4DE0-9EAB-8E49DA221364Q39882226-59C32ACF-AB69-4CA1-91C1-FBB2FA5B58FFQ40116177-F5FEF97D-0C93-4959-97F0-9F0A08448D6EQ40129024-66920E8A-6AD7-4031-88AE-BC14177F0C64Q40129920-7E4EAF21-6B0E-4FD3-B64F-81AE84D815BAQ40132148-4881A0A3-DFA3-46BB-9754-CD876F086343Q40546140-9F334848-5D4D-49A5-8F3F-B324DE6CD149Q40555242-E79FAB94-FF79-4DE3-BBBC-4768956BABBFQ40794281-2C730773-0994-4DDA-A58E-914829C94430
P2860
Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Four virally determined nuclea ...... n-Barr virus-transformed cells
@ast
Four virally determined nuclea ...... n-Barr virus-transformed cells
@en
type
label
Four virally determined nuclea ...... n-Barr virus-transformed cells
@ast
Four virally determined nuclea ...... n-Barr virus-transformed cells
@en
prefLabel
Four virally determined nuclea ...... n-Barr virus-transformed cells
@ast
Four virally determined nuclea ...... n-Barr virus-transformed cells
@en
P2093
P2860
P356
P1476
Four virally determined nuclea ...... n-Barr virus-transformed cells
@en
P2093
B Ehlin-Henriksson
P2860
P304
P356
10.1073/PNAS.83.5.1499
P407
P577
1986-03-01T00:00:00Z